The US Institute of Medicine (IoM) has recently released a report supporting the movement for full transparency in clinical trial information saying, “releasing information is in the public interest and maximizes the contributions made by clinical trial participants...
Fred Upton, chairman of the House Energy and Commerce Committee, and Rep. Diana DeGette have recently launched the 21st Century Cures initiative, a bill intended to improve clinical trials and expedite the drug and device approval process. Upton and Degette plan to...
Last month at Partnerships in Clinical Trials (PCT) in Barcelona, Spain, TransCelerate Biopharma CEO, Dalvir Gill explained to contract research and pharma industry representatives that working together to fix issues is the key to simplifying and expediting the...
Pearl Pathways is pleased to announce a global partnership with Brandwood Biomedical, an Australia-headquartered regulatory and quality services company with offices throughout Asia. This collaboration allows both companies to provide on-the-ground support to clients...
Pearl IRB has Full Board meetings scheduled for December 3, 10, and 17. There will be no meetings on December 24 or 31. The regularly scheduled Full Board meetings will resume on January 7, 2015. If you have an urgent IRB concern, please contact us at least two weeks...
